|
Variables
|
PCI population—410
|
CABG—559
|
P value
|
|---|
|
Age (IQR)
|
61 (54–67)
|
63 (57–69)
|
< 0.001
|
|
Male sex (%)
|
258 (62.9)
|
398 (71.2)
|
< 0.001
|
|
Hypertension (%)
|
331 (80.9)
|
444 (79.4)
|
0.564
|
|
Diabetes (%)
|
247 (60.2)
|
287 (51.3)
|
0.006
|
|
Smoke history (%)
|
179 (43.7)
|
308 (55.1)
|
< 0.001
|
|
EF (IQR)
|
62.5 (58–69)
|
60 (51–64)
|
< 0.001
|
|
SYNTAX score I (IQR)
|
14 (10–19.1)
|
23 (17–29.5)
|
< 0.001
|
|
Residual SYNTAX score (IQR)
|
4.7 (0–9)
|
2 (0–6.5)
|
< 0.001
|
|
SYNTAX score II (IQR)
|
28.7 (23–34.2)
|
25.4 (19.2–32.8)
|
< 0.001
|
|
PAD (%)
|
22 (5.4)
|
67 (12)
|
< 0.001
|
|
COPD (%)
|
6 (1.5)
|
27 (4.8)
|
0.004
|
|
GFR (IQR)
|
67 (57–80)
|
69 (58–79)
|
0.514
|
|
LDL (IQR)
|
117 (89–145)
|
106 (83–134)
|
0.002
|
|
Aspirin/clopidogrel (%)
|
406 (99)
|
553 (98.9%)
|
0.882
|
|
Statin (%)
|
400 (97.6)
|
553 (98.9%)
|
0.099
|
|
Three-vessel disease (%)
|
215 (51)
|
220 (39.4)
|
< 0.001
|
|
Left-main (%)
|
15 (3.7)
|
116 (20.8)
|
< 0.001
|
|
Complete revascularization (%)
|
106 (25.9)
|
224 (40.1)
|
< 0.001
|
|
Drug eluting stent (%)
|
152 (37.1)
|
N.A
|
–
|
|
On-pump CABG (%)
|
NA
|
323 (57.8)
|
–
|
|
Left internal thoracic artery (%)
|
NA
|
546 (97.7)
|
–
|
|
Second arterial graft (%)
|
NA
|
69 (12.3)
|
–
|
|
Number of grafts (SD)
|
NA
|
2.9 (± 0.64)
|
–
|
- CABG coronary artery bypass grafting, COPD chronic obstructive pulmonary disease, EF ejection fraction, GFR glomerular filtration rate, IQR interquartile range, LDL low density lipoprotein, NA non-available, PAD peripheral artery disease, SD standard deviation
